Baxter International Inc.
$18.8
▲
1.68%
2026-04-22 10:12:13
www.baxter.com
NYQ: BAX
Explore Baxter International Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$9.79 B
Current Price
$18.8
52W High / Low
$32.68 / $15.73
Stock P/E
—
Book Value
$11.92
Dividend Yield
0.21%
ROCE
1.04%
ROE
-13.71%
Face Value
—
EPS
$-1.75
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
37,500
Beta
0.62
Debt / Equity
160.28
Current Ratio
2.31
Quick Ratio
1.56
Forward P/E
8.47
Price / Sales
0.79
Enterprise Value
$16.61 B
EV / EBITDA
8.23
EV / Revenue
1.48
Rating
Hold
Target Price
$22.12
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
- Meaningful dividend yield is available.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Leverage is relatively high.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | West Pharmaceutical Services, Inc. | $274.81 | 40.51 | $19.81 B | 0.33% | 17.6% | 16.86% | $322.34 / $193.05 | $44.11 |
| 2. | STAAR Surgical Company | $25.53 | — | $1.27 B | — | -11.99% | -21.7% | $30.81 / $15.59 | $6.97 |
| 3. | Bionano Genomics, Inc. | $1.31 | — | $14.53 M | — | -65.83% | -66.15% | $5.5 / $1.06 | $4.14 |
| 4. | ICU Medical, Inc. | $130.58 | 4,461.76 | $3.27 B | — | 3.08% | 0.04% | $160.29 / $107 | $86.03 |
| 5. | DENTSPLY SIRONA Inc. | $12.79 | — | $2.61 B | 5.5% | 6.17% | -36.43% | $17.18 / $9.85 | $6.71 |
| 6. | GlucoTrack, Inc. | $0.78 | — | $1.55 M | — | -524.96% | 381.2% | $15.9 / $0.62 | $3.06 |
| 7. | Teleflex Incorporated | $131.95 | — | $5.84 B | 1.03% | 4.14% | 1.58% | $138.93 / $100.18 | $70.7 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 2.97 B | 2.83 B | 2.81 B | 2.62 B | 2.75 B | — |
| Operating Profit | -244 M | 172 M | 191 M | 58 M | -1 M | — |
| Net Profit | -1.13 B | -46 M | 91 M | 126 M | -512 M | — |
| EPS in Rs | -2.18 | -0.09 | 0.18 | 0.24 | -0.99 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 11.24 B | 10.64 B | 10.36 B | 10.06 B |
| Operating Profit | 177 M | 439 M | 707 M | -33 M |
| Net Profit | -957 M | -649 M | 2.66 B | -2.43 B |
| EPS in Rs | -1.85 | -1.26 | 5.14 | -4.71 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 20.05 B | 25.78 B | 28.28 B | 28.29 B |
| Total Liabilities | 13.95 B | 18.76 B | 19.81 B | 22.39 B |
| Equity | 6.13 B | 6.96 B | 8.4 B | 5.83 B |
| Current Assets | 6.87 B | 8.85 B | 9.6 B | 8.01 B |
| Current Liabilities | 2.97 B | 6.51 B | 6.5 B | 4.75 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 845 M | 1.02 B | 1.73 B | 1.21 B |
| Investing CF | 2.84 B | -626 M | 3.21 B | -931 M |
| Financing CF | -4.22 B | -1.08 B | -3.49 B | -1.44 B |
| Free CF | 323 M | 559 M | 1.29 B | 576 M |
| Capex | -522 M | -460 M | -436 M | -635 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 2.66% | 3.01% | — | — |
| Earnings Growth % | -124.44% | 209.17% | — | — |
| Profit Margin % | -6.1% | 25.64% | -24.19% | — |
| Operating Margin % | 4.13% | 6.82% | -0.33% | — |
| Gross Margin % | 37.46% | 40.06% | 35.29% | — |
| EBITDA Margin % | 10.49% | 16.74% | -17.53% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-02-27 | $0.01 |
| 2025-11-28 | $0.01 |
| 2025-08-29 | $0.17 |
| 2025-05-30 | $0.17 |
| 2025-02-28 | $0.17 |
Stock Splits
No stock split history available.